ArticleAging2024

Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.

Wenpeng Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.